Gilead Sciences IncGILD:NSQ

115.24
1.02 / 0.89%
3.02m
61.91%
0.7413
Real-time price in USDToday's changeShares traded1 year changeBeta
As of Oct 31 2014 14:17 GMT.

Summary

Gilead Sciences Inc (GILD:NSQ) set a new 52-week high during today's trading session when it reached 116.83. Over this period, the share price is up 62.38%.

52-week range
Today
63.50
Apr 11 2014
116.83
Oct 31 2014
Markit short selling activity
Low
Medium
High
Open115.90
Day high116.83
Day low114.68
Bid115.26
Offer115.30
Previous close114.22
Average volume14.39m
Shares outstanding1.51bn
Free float1.50bn
P/E (TTM)20.20
Market cap172.66bn USD
EPS (TTM)5.65 USD
As of Oct 31 2014 14:17 GMT.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Gilead Sciences Inc+3.87%+8.03%+47.99%+61.57%+440.54%
S&P 500 INDEX+1.53%+1.13%+6.03%+13.56%+92.50%
USA/HEALTH CARE+2.59%+4.62%+13.49%+21.40%--
USA/BIOTECHNOLOGY+3.46%+7.90%+27.49%+31.44%--
Data delayed at least 15 minutes, as of Oct 31 2014 14:02 GMT.
© Thomson Reuters Click for restrictions.

Real-time data provided by BATS.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.